Subscribe to the Volv Global Newsletter, published every two to three months. Editions bring you new research and evidence to draw on, and project experience to put to use. You will also see how our machine learning methodologies help pharmaceutical teams and clinicians find patients with difficult-to-diagnose diseases earlier, and predict how a diagnosed patient’s disease is likely to progress, so that more patients reach the treatment they need, sooner.
You can find an archive of our newsletters at the bottom of this page.
This initial edition’s throughline is oncology, from the timing of treatment decisions to the consequences of late diagnosis in breast cancer, with a neuroendocrine tumour case study at its heart.
